Login

Aram Mangasarian , CEO, NOXXON Pharma 00:00:00

Share On Facebook Share On Twitter

Aram Mangasarian présente Noxxon Pharma

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Navigating Basel Regulatory Capital: Challenges and Evolution | Insights from Basel Practitioners
00:10:00
RingCentral CEO Vlad Shmunis discusses the company's new AI product launch.
00:00:00
Gianrico Farrugia, M.D. Gastroenterologist, Mayo Clinic
00:10:00
DOTD CEO Milan Patel and CFO Paraag Amin provide an overview of the company's full-year results for the period ending June 30, 2021, highlighting key operational achievements and financial performance, and outlining future focus areas​|Milan Patel, CEO of
00:10:00
Fund established by operators for operators|Arielle Zuckerberg,General Partner,Long Journey Ventures
00:10:00
Najeeb Ghauri, Founder, Chairman, and CEO of NETSOL Technologies Inc., discusses their smart software for car dealers with Sully and Mike.
00:10:00
"Brinova: Transforming Communities with Affordable Housing in Southern Sweden"|CEO,Brinova Fastigheter AB (publ)
00:10:00
Credit Suisse CEO Addresses Record Fund Outflows and Profit Outlook Amidst Challenging Year|Ulrich Koerner,CEO,Credit Suisse Group AG
00:10:00
Celebrating a decade of growth and success, multi-brand franchisor anticipates continued expansion | Stephen Hemsley, CEO, Franchise Brands PLC.
00:10:00
World Needs More Financial Innovation And Less Financial Engineering.|Micky Malka,Founder,Ribbit Capital
00:10:00
Riverside Resources: Driving Exploration Success in North America
00:10:00
Navigating Raw Material Challenges: Tire Industry Demand and Growth Outlook for 2023|Mr. Suresh Sodani,Managing Director,Century Enka Ltd

© 2026 Nehu